Bamco Inc. NY Has $71.61 Million Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Bamco Inc. NY trimmed its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 2.3% during the third quarter, HoldingsChannel reports. The fund owned 339,300 shares of the company’s stock after selling 8,000 shares during the period. Bamco Inc. NY’s holdings in Inspire Medical Systems were worth $71,609,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. Wasatch Advisors LP increased its holdings in Inspire Medical Systems by 1.6% during the 3rd quarter. Wasatch Advisors LP now owns 1,323,470 shares of the company’s stock worth $279,318,000 after purchasing an additional 20,481 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Inspire Medical Systems by 32.3% during the second quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company’s stock worth $105,433,000 after buying an additional 192,238 shares during the period. William Blair Investment Management LLC raised its position in Inspire Medical Systems by 1.8% in the 2nd quarter. William Blair Investment Management LLC now owns 770,413 shares of the company’s stock valued at $103,104,000 after buying an additional 13,602 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Inspire Medical Systems by 4.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 281,165 shares of the company’s stock valued at $59,340,000 after acquiring an additional 11,939 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its stake in Inspire Medical Systems by 798.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock valued at $56,530,000 after acquiring an additional 238,034 shares in the last quarter. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Down 0.6 %

Shares of NYSE INSP opened at $192.76 on Monday. The business’s 50 day moving average price is $197.96 and its two-hundred day moving average price is $176.45. The company has a market cap of $5.78 billion, a PE ratio of 180.15 and a beta of 1.36. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The business had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same period in the previous year, the firm earned ($0.29) EPS. The firm’s revenue was up 32.6% compared to the same quarter last year. As a group, research analysts anticipate that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

INSP has been the topic of a number of recent research reports. Wells Fargo & Company lifted their price objective on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $220.00 to $255.00 in a research report on Wednesday, November 20th. Robert W. Baird raised their price objective on Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a report on Tuesday, November 5th. KeyCorp lowered their target price on Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $200.00 price target (up from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $233.58.

Insider Activity

In related news, Director Shawn Mccormick sold 800 shares of Inspire Medical Systems stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $220.00, for a total transaction of $176,000.00. Following the completion of the sale, the director now owns 23,140 shares of the company’s stock, valued at approximately $5,090,800. The trade was a 3.34 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 4.10% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.